EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY-NC-ND 4.0

Antibiotic Stewardship in Cirrhosis: Current Recommendations and Clinical Challenges

Solaiman Ezzafzafi iD, Kimberly K I M Bot, Lucas H P Bernts, Reinier M van Hest iD, Alastair O'Brien iD, Michiel A van Agtmael iD, Jarne M van Hattem iD, Marten A Lantinga iD

United European Gastroenterology Journal · 2026-10 · 14 (8)

DOI: 10.1002/ueg2.70317 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift United European Gastroenterology Journal, online erschienen am 17.10.2026. Verfasst von Solaiman Ezzafzafi und 7 weiteren Autor:innen. Beteiligte Einrichtung: Department of Gastroenterology and Hepatology, Amsterdam Gastroenterology Endocrinology Metabolism, Amsterdam UMC, University of Amsterdam, Amsterdam…. Hauptthemen laut MEDLINE: Liver Cirrhosis, Anti-Bacterial Agents, Antimicrobial Stewardship, Antibiotic Prophylaxis. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 97 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Bacterial infections are a major cause of mortality in cirrhosis, with antibiotic prophylaxis and empirical treatment embedded in international guidelines. However, the prevalence of multidrug‐resistant organisms and the epidemiology of infections have shifted considerably in recent decades. This review critically appraises the evidence underlying guideline recommendations on antibiotic prophylaxis for spontaneous bacterial peritonitis and acute variceal bleeding in cirrhosis, and antimicrobial management in acute liver failure. The evidence‐underlying current recommendations is limited and predates the current era of widespread antimicrobial resistance, challenging their applicability in current practice. Emerging evidence suggests that primary prophylaxis should be reconsidered, alternatives such as rifaximin warrant further evaluation against established fluoroquinolone regimens, and shorter antibiotic courses may be non‐inferior to standard durations. New double‐blind placebo‐controlled, non‐inferiority and Bayesian trials are needed to evaluate antibiotic regimens and microbiome‐ and barrier‐directed interventions, supported by improved diagnostics, while minimising treatment duration, toxicity and selection for antimicrobial resistance.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Liver CirrhosisAnti-Bacterial AgentsAntimicrobial StewardshipAntibiotic ProphylaxisPeritonitisBacterial InfectionsHumansGastrointestinal HemorrhagePractice Guidelines as TopicEsophageal and Gastric VaricesRifaximin

Stichwörter der Autor:innen

acute liver failureantibiotic prophylaxisantimicrobial resistanceantimicrobial stewardshipcirrhosisspontaneous bacterial peritonitisvariceal bleeding

Substanzen

Anti-Bacterial AgentsRifaximin

Autor:innen und Institutionen

  • Department of Gastroenterology and Hepatology, Amsterdam Gastroenterology Endocrinology Metabolism, Amsterdam UMC, University of Amsterdam, Amsterdam, the Netherlands.
  • Department of Hospital Pharmacy and Clinical Pharmacology, Amsterdam UMC, University of Amsterdam, Amsterdam, the Netherlands.
  • Department of Medical Microbiology, Radboudumc, Radboud University Nijmegen, Nijmegen, the Netherlands.
  • Centre for Immunobiology and Infection, Blizard Institute, Queen Mary University of London, London, UK.
  • Department of Medicine, Division of Infectious Diseases, Amsterdam UMC, University of Amsterdam, Amsterdam, the Netherlands.
  • Department of Medical Microbiology and Infection Prevention, Amsterdam UMC, University of Amsterdam, Amsterdam, the Netherlands.

ORCID-Profile: Solaiman Ezzafzafi, Reinier M van Hest, Alastair O'Brien, Michiel A van Agtmael, Jarne M van Hattem, Marten A Lantinga

Zitieren

APA

Ezzafzafi, S., Bot, K. K. I. M., Bernts, L. H. P., van Hest, R. M., O'Brien, A., van Agtmael, M. A., van Hattem, J. M., & Lantinga, M. A. (2026). Antibiotic Stewardship in Cirrhosis: Current Recommendations and Clinical Challenges. United European Gastroenterology Journal, 14(8). https://doi.org/10.1002/ueg2.70317

Vancouver

Ezzafzafi S, Bot KKIM, Bernts LHP, van Hest RM, O'Brien A, van Agtmael MA, et al. Antibiotic Stewardship in Cirrhosis: Current Recommendations and Clinical Challenges. United European Gastroenterology Journal. 2026;14(8). doi:10.1002/ueg2.70317

BibTeX
@article{Ezzafzafi2026,
  author = {Ezzafzafi, Solaiman and Bot, Kimberly K I M and Bernts, Lucas H P and van Hest, Reinier M and O'Brien, Alastair and van Agtmael, Michiel A and van Hattem, Jarne M and Lantinga, Marten A},
  title = {Antibiotic Stewardship in Cirrhosis: Current Recommendations and Clinical Challenges},
  journal = {United European Gastroenterology Journal},
  year = {2026},
  volume = {14},
  number = {8},
  doi = {10.1002/ueg2.70317}
}
Kostenlos starten →